Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
OTHER OTC:NKGN
NKGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $1.05
Previous CloseN/A
Volume116.73K
Average Volume (3M)121.63K
Market Cap
$7.64M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.29
Shares Outstanding44,947,590
10 Day Avg. Volume20,269
30 Day Avg. Volume121,625
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NKGen Biotech News
NKGN FAQ
What was NKGen Biotech’s price range in the past 12 months?
NKGen Biotech lowest stock price was $0.10 and its highest was $1.05 in the past 12 months.
What is NKGen Biotech’s market cap?
NKGen Biotech’s market cap is $7.64M.
When is NKGen Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NKGen Biotech’s earnings last quarter?
Currently, no data Available
Is NKGen Biotech overvalued?
According to Wall Street analysts NKGen Biotech’s price is currently Overvalued.
Does NKGen Biotech pay dividends?
NKGen Biotech does not currently pay dividends.
What is NKGen Biotech’s EPS estimate?
NKGen Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NKGen Biotech have?
NKGen Biotech has 44,947,590 shares outstanding.
What happened to NKGen Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NKGen Biotech?
Currently, no hedge funds are holding shares in NKGN
NKGen Biotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 549.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.7%
Last 30 Days ▼ 6.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-82.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.76%
Trailing 12-Months
Company Description
NKGen Biotech
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
NKGen Biotech (NKGN) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Palatin Technologies
―
GT Biopharma
―
Creative Medical Technology Holdings
―
Spruce Biosciences
―
Apollomics
―
Ownership Overview
56.82% Insiders
0.78% Mutual Funds
1.99% Other Institutional Investors
40.41% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---